Cargando…
The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics
Group A Streptococcus (GAS) infections result in a considerable underappreciated burden of acute and chronic disease globally. A 2018 World Health Assembly resolution calls for better control and prevention. Providing guidance on global health research needs is an important World Health Organization...
Autores principales: | Vekemans, Johan, Gouvea-Reis, Fernando, Kim, Jerome H, Excler, Jean-Louis, Smeesters, Pierre R, O’Brien, Katherine L, Van Beneden, Chris A, Steer, Andrew C, Carapetis, Jonathan R, Kaslow, David C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695511/ https://www.ncbi.nlm.nih.gov/pubmed/30624673 http://dx.doi.org/10.1093/cid/ciy1143 |
Ejemplares similares
-
A Systematic Framework for Prioritizing Burden of Disease Data Required for Vaccine Development and Implementation: The Case for Group A Streptococcal Diseases( )
por: Moore, Hannah C, et al.
Publicado: (2022) -
Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics
por: Vekemans, Johan, et al.
Publicado: (2019) -
Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring
por: Asturias, Edwin J, et al.
Publicado: (2023) -
A roadmap for human trials of xenotransplantation
por: Porrett, Paige M., et al.
Publicado: (2022) -
The Streptococcus pyogenes vaccine landscape
por: Walkinshaw, Donald R., et al.
Publicado: (2023)